The present invention relates to a Lactobacillus acidophilus KBL409 strain and uses thereof, wherein the Lactobacillus acidophilus KBL409 (deposit number KCTC 13518BP) strain according to the present invention reduces inflammation of the kidney, reduce the concentration of uremic toxins such as blood urea nitrogen, creatinine and p-cresol to protect the kidney, and thus may be usefully utilized for prophylactic and therapeutic applications of renal diseases including improving renal function and chronic renal failure.

The present disclosure provides a feed additive for domesticated animals that is capable of increasing feed performance, as well as associated methods for promoting growth and zootechnical performance in domesticated animals. The animal feed additive provided contains Total Lignans standardized in the contents of Furoguaiacin-like compounds and Guaiacin-like compounds. The present disclosure also describes methods for improving growth via the dietary inclusion of Total Lignans standardized in Furoguaiacin-like compounds and Guaiacin-like compounds.

The present disclosure provides a recirculating aquaculture system comprising a) a wastewater treatment system and b) a polyhydroxyalkanoate (PHA) production system. In particular, poly(3-hydroxybutyrate) (PHB) can be utilized as the PHA in such a system. Methods of treating wastewater for reuse by contacting the wastewater with one or more zeolites to remove material from the wastewater and reusing the treated wastewater are also provided as well as methods of producing a PHA such as PHB from organic waste. Moreover, food compositions comprising a PHA biomass as well as associated methods are also provided.

The present disclosure provides a recirculating aquaculture system comprising a) a wastewater treatment system and b) a polyhydroxyalkanoate (PHA) production system. In particular, poly(3-hydroxybutyrate) (PHB) can be utilized as the PHA in such a system. Methods of treating wastewater for reuse by contacting the wastewater with one or more zeolites to remove material from the wastewater and reusing the treated wastewater are also provided as well as methods of producing a PHA such as PHB from organic waste. Moreover, food compositions comprising a PHA biomass as well as associated methods are also provided.

The present invention discloses a method for preserving a probiotic composition, including: providing a bacterial cell suspension, which is one or more bacterial cell suspensions of a bacterium or Saccharomyces boulardii; mixing the bacterial cell suspension with a sodium alginate solution or an alginic acid solution; and adding the mixture to a calcium ion solution until the mixture is immobilized in a shape. The technology of the present invention has the effects of long-term preservation at room temperature and resistance to high temperature, and can be applied to ordinary bacterial strains, without being limited to a small number of bacterial species able to form endospore, and without requiring the strains to be frozen for preservation. The method of the present invention can be applied to the preparation of aquatic feeds, animal feeds, or probiotics that human beings need.

The present invention discloses a method for preserving a probiotic composition, including: providing a bacterial cell suspension, which is one or more bacterial cell suspensions of a bacterium or Saccharomyces boulardii; mixing the bacterial cell suspension with a sodium alginate solution or an alginic acid solution; and adding the mixture to a calcium ion solution until the mixture is immobilized in a shape. The technology of the present invention has the effects of long-term preservation at room temperature and resistance to high temperature, and can be applied to ordinary bacterial strains, without being limited to a small number of bacterial species able to form endospore, and without requiring the strains to be frozen for preservation. The method of the present invention can be applied to the preparation of aquatic feeds, animal feeds, or probiotics that human beings need.

The presently disclosed subject matter relates to a composition and method of using the composition for oral delivery of a bioactive agent to a subject. More particularly, the presently disclosed subject matter relates to a composition comprising an effective amount of at least one bioactive agent layered over a substrate and a method of reducing zoonotic infectious disease by administering the composition to a subject. The presently disclosed subject matter further relates to a method of preparing the composition.

The presently disclosed subject matter relates to a composition and method of using the composition for oral delivery of a bioactive agent to a subject. More particularly, the presently disclosed subject matter relates to a composition comprising an effective amount of at least one bioactive agent layered over a substrate and a method of reducing zoonotic infectious disease by administering the composition to a subject. The presently disclosed subject matter further relates to a method of preparing the composition.

Provided herein are poultry diets containing phytase polypeptides or fragments thereof wherein the diet contains no or substantially no inorganic phosphate.

Provided herein are poultry diets containing phytase polypeptides or fragments thereof wherein the diet contains no or substantially no inorganic phosphate.